BD PartnerPath™ Program aims to support pharmaceutical organizations that value speed to market in combination product development.2
The BD PartnerPath™ Program aims to help anticipate obstacles, mitigate risks and solve operational challenges for customers during combination product development.
Through our program, you will gain access to low quantities* of individually available products and preconfigured product sets along with the proactive delivery of supporting documentation to help streamline device selection, inform development efforts, and help de-risk device-related aspects of the development process. 2,4
Developing a combination product can be difficult. You may encounter many challenges that can delay development and launch. Ultimately, these delays increase costs, negatively impacting profitability and can decrease viability of market launch.2 Common challenges include:
Primary and secondary device identification
Drug Compatibility
System Integration
Operational feasibility
Testing feasibility
Regulatory registration
For complex and novel drugs, you need greater precision from the devices you choose. Primary containers, components and secondary devices should work together without impacting drug makeup and the ability to safely and effectively inject your drug.2 BD has the experience and expertise to help you efficiently select combination solutions to de-risk device related aspects of the development process.1 Our BD PartnerPath™ Program aims to support device related aspects of your drug’s development, helping to ensure you meet your drug’s launch timeliness and performance targets.
With the BD PartnerPath™ Program, you now have access to small-scale quantities of the primary and secondary delivery solutions to meet your needs for clinical development—along with supporting documentation and extensive BD expertise in managing system interfaces.1,3,4
So your drug gets to market as quickly as possible—and performs under real-life conditions.
Gain timely access to small quantities* of commercially available solutions for use in combination products- from early development through assembly validation.
*minimum purchase quantity at the lowest sterilized package configuration e.g. syringe tub or plunger stopper bag
Available as individual products or preconfigured product sets, our solutions can help streamline the device selection process and promote assurance in the combination of device components*.1
* The BD PartnerPath™ Program is currently available in North America, Europe, and certain regions of Greater Asia.
We can help you streamline device related aspects of your development and registration activities by proactively providing supporting documentation.4
Our expertise can enhance device related aspects of your combination product’s development. Our experience enables BD to help trouble shoot combination product development issues and recommend preconfigured product sets to meet your unique needs.1,3,4
to our portfolio of integrated drug delivery solutions
to accommodate small quantities for development stage activities
to access technical documentation and drawings to support regulatory submission and drug registration
in combination product development activities and regulatory registration
in choosing primary and secondary systems that support your drug’s goals for performance
